Glucose Intolerance, Insulin Resistance, and Pathological Features of Alzheimer Disease in the Baltimore Longitudinal Study of Aging
Open accessAbstract
IMPORTANCE: Peripheral glucose homeostasis has been implicated in the pathogenesis of Alzheimer disease (AD). The relationship among diabetes mellitus, insulin, and AD is an important area of investigation. However, whether cognitive impairment seen in those with diabetes is mediated by excess pathological features of AD or other related abnormalities, such as vascular disease, remains unclear. OBJECTIVE: To investigate the association between serial measures of glucose intolerance and insulin resistance and in vivo brain β-amyloid burden, measured with carbon 11–labeled Pittsburgh Compound B (11C-PiB), and AD pathology at autopsy. DESIGN: Scores calculated from the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) and Braak criteria were correlated with measures of hyperglycemia, hyperinsulinemia, glucose intolerance, and insulin resistance in 197 participants who underwent autopsy after death and who had undergone 2 or more oral glucose tolerance tests (OGTT) using grouped analyses and a continuous mixed-models analysis. The same measures of glucose intolerance and insulin resistance were also correlated with brain 11C-PiB retention in an additional 53 living subjects from the Baltimore Longitudinal Study of Aging neuroimaging study. SETTING: Prospective, serially assessed cohort of community-dwelling subjects. PARTICIPANTS: Cohort 1 consisted of 197 participants enrolled in the Baltimore Longitudinal Study of Aging who had 2 or more OGTTs during life and a complete brain autopsy after death. Cohort 2 consisted of 53 living subjects who had 2 or more OGTTs and underwent brain 11C-PiB positron emission tomography. EXPOSURES: Autopsy and 11C-PiB positron emission tomography. MAIN OUTCOMES AND MEASURES: The correlation of brain markers of AD, including CERAD score, Braak score, and 11C-PiB retention, with serum markers of glucose homeostasis using grouped and continuous mixed-models analyses. RESULTS: We found no significant correlations between measures of brain AD pathology or 11C-PiB β-amyloid load and glucose intolerance or insulin resistance in subjects who had a mean (SD) of 6.4 (3.2) OGTTs during 22.1 (8.0) years of follow-up. Thirty subjects with frank diabetes mellitus who received medications also had AD pathology scores that were similar to those of the cohort as a whole. CONCLUSIONS AND RELEVANCE: In this prospective cohort with multiple assessments of glucose intolerance and insulin resistance, measures of glucose and insulin homeostasis are not associated with AD pathology and likely play little role in AD pathogenesis. Long-term therapeutic trials are important to elucidate this issue.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Many studies have failed to establish a relationship between systemic insulin resistance or type 2 diabetes and molecular symptoms of neurodegenerative diseases.
“many studies have failed to establish a relationship between systemic insulin resistance or type 2 diabetes and molecular symptoms of neurodegenerative diseases 142”
From Intranasal insulin (2021) · cites this paper as [142]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,769 · see citing works
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · see citing works
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · see citing works
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017 · see citing works
Self-citationLinear Mixed Models for Longitudinal Data
Verbeke, G. (1997) · Lecture Notes in Statistics · doi:10.1007/978-1-4612-2294-1_3 · Cited by 3,506 · see citing works
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175 · see citing works
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061 · see citing works
Self-citationTalbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871 · see citing works
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function
Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258 · see citing works
Craft, S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.233 · Cited by 1,253 · see citing works
Increased Risk of Type 2 Diabetes in Alzheimer Disease
Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950 · see citing works
How does diabetes accelerate Alzheimer disease pathology?
Sims-Robinson, C., Kim, B., Rosko, A., & Feldman, E. L. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.130 · Cited by 492 · see citing works
Insulin resistance is associated with the pathology of Alzheimer disease: The Hisayama Study
Matsuzaki, T., Sasaki, K., Tanizaki, Y., Hata, J., Fujimi, K., Matsui, Y., Sekita, A., Suzuki, S. O., Kanba, S., Kiyohara, Y., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181eee25f · Cited by 432 · see citing works
Glucose tolerance status and risk of dementia in the community
Ohara, T., Doi, Y., Ninomiya, T., Hirakawa, Y., Hata, J., Iwaki, T., Kanba, S., & Kiyohara, Y. (2011) · Neurology · doi:10.1212/wnl.0b013e31822f0435 · Cited by 420 · see citing works
Convit, A., Wolf, O. T., Tarshish, C., & de Leon, M. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336073100 · Cited by 347 · see citing works
Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study
Schrijvers, E. M. C., Witteman, J. C. M., Sijbrands, E. J. G., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ffe4f6 · Cited by 328 · see citing works
Insulin in Central Nervous System: More than Just a Peripheral Hormone
Duarte, A. I., Moreira, P. I., & Oliveira, C. R. (2012) · Journal of Aging Research · doi:10.1155/2012/384017 · Cited by 324 · see citing works
Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia
Yaffe, K., Falvey, C., Hamilton, N., Schwartz, A. V., Simonsick, E. M., Satterfield, S., Cauley, J. A., Rosano, C., Launer, L. J., Strotmeyer, E. S., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1117 · Cited by 313 · see citing works
Resnick, S. M., Sojkova, J., Zhou, Y., An, Y., Ye, W., Holt, D. P., Dannals, R. F., Mathis, C. A., Klunk, W. E., Ferrucci, L., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d3e3e9 · Cited by 288 · see citing works
Self-citationDiabetes is related to cerebral infarction but not to AD pathology in older persons
Arvanitakis, Z., Schneider, J. A., Wilson, R. S., Li, Y., Arnold, S. E., Wang, Z., & Bennett, D. A. (2006) · Neurology · doi:10.1212/01.wnl.0000247053.45483.4e · Cited by 280 · see citing works
Effect of infarcts on dementia in the Baltimore longitudinal study of aging
Troncoso, J. C., Zonderman, A. B., Resnick, S. M., Crain, B., Pletnikova, O., & O'Brien, R. J. (2008) · Annals of Neurology · doi:10.1002/ana.21413 · Cited by 219 · see citing works
Self-citationCognitive Function in an Elderly Population With Persistent Impaired Glucose Tolerance
Vanhanen, M., Koivisto, K. J., Kuusisto, J., Mykkänen, L. M., Helkala, E., Hänninen, T., Riekkinen, P. J., Soininen, H. S., & Laakso, M. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.398 · Cited by 187 · see citing works
Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects
Heitner, J., & Dickson, D. (1997) · Neurology · doi:10.1212/wnl.49.5.1306 · Cited by 173 · see citing works
Bruce, D. G., Casey, G. P., Grange, V., Clarnette, R. C., Almeida, O. P., Foster, J. K., Ives, F. J., & Davis, T. M. E. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00084-6 · Cited by 145 · see citing works
Influence of Type 2 Diabetes on Brain Volumes and Changes in Brain Volumes
Espeland, M. A., Bryan, R. N., Goveas, J. S., Robinson, J. G., Siddiqui, M., Liu, S., Hogan, P. E., Casanova, R., Coker, L. H., Yaffe, K. S., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0555 · Cited by 128 · see citing works
Self-citationBourdel‐Marchasson, I., Dubroca, B., Manciet, G., Décamps, A., Émeriau, J. P., & Dartigues, J. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb00943.x · Cited by 113 · see citing works
Zhou, Y., Resnick, S. M., Ye, W., Fan, H., Holt, D. P., Klunk, W. E., Mathis, C. A., Dannals, R. F., & Wong, D. F. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.03.004 · Cited by 99 · see citing works
Self-citationLaron, Z. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450902949012 · Cited by 97 · see citing works
Diabetes and Cognitive Systems in Older Black and White Persons
Arvanitakis, Z., Bennett, D. A., Wilson, R. S., & Barnes, L. L. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181a6bed5 · Cited by 76 · see citing works
Lindeman, R. D., Romero, L. J., LaRue, A. A., Yau, C. L., Schade, D. S., Koehler, K. M., Baumgartner, R., & Garry, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1567 · Cited by 75 · see citing works
Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging
Burns, J. M., Honea, R. A., Vidoni, E. D., Hutfles, L. J., Brooks, W. M., & Swerdlow, R. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.011 · Cited by 72 · see citing works
Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing
Dolan, D., Troncoso, J., Resnick, S. M., Crain, B. J., Zonderman, A. B., & O'Brien, R. J. (2010) · Brain · doi:10.1093/brain/awq141 · Cited by 70 · see citing works
Self-citationLongitudinal Cerebral Blood Flow and Amyloid Deposition: An Emerging Pattern?
Sojkova, J., Beason‐Held, L. L., Zhou, Y., An, Y., Kraut, M. A., Ye, W., Ferrucci, L., Mathis, C. A., Klunk, W. E., Wong, D. F., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.051946 · Cited by 70 · see citing works
Self-citationMuller, D. C., Elahi, D., Tobin, J. D., & Andres, R. (1996) · Aging Clinical and Experimental Research · doi:10.1007/bf03340110 · Cited by 62 · see citing works
Glucose and Insulin Measurements from the Oral Glucose Tolerance Test and Mortality Prediction
Metter, E. J., Windham, B. G., Maggio, M. G., Simonsick, E. M., Ling, S. M., Egan, J. M., & Ferrucci, L. (2008) · Diabetes Care · doi:10.2337/dc07-2102 · Cited by 46 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Arnold, S. E., Arvanitakis, Z., Macauley-Rambach, S. L., Koenig, A. M., Wang, H.-Y., Ahima, R. S., Craft, S., Gandy, S., Buettner, C., Stoeckel, L. E., et al. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.185 · Cited by 1,597 · see citing works
Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans
Kullmann, S., Heni, M., Hallschmid, M., Fritsche, A., Preissl, H. T., & Häring, H. (2016) · Physiological Reviews · doi:10.1152/physrev.00032.2015 · Cited by 632 · see citing works
Biessels, G. J., Strachan, M. W. J., Visseren, F. L. J., Kappelle, L. J., & Whitmer, R. A. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70088-3 · Cited by 555 · see citing works
Hippocampal insulin resistance and cognitive dysfunction
Biessels, G. J., & Reagan, L. P. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn4019 · Cited by 536 · see citing works
Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
Barrett, E. J., Liu, Z., Khamaisi, M., King, G. L., Klein, R., Klein, R., Hughes, T. M., Craft, S., Freedman, B. I., Bowden, D. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01922 · Cited by 519 · see citing works
Evidence for brain glucose dysregulation in Alzheimer’s disease
An, Y., Varma, V., Varma, S., Casanova, R., Dammer, E., Pletnikova, O., Chia, C. W., Egan, J. M., Ferrucci, L., Troncoso, J., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.09.011 · Cited by 454 · see citing works
Self-citationVerdile, G., Keane, K. N., Cruzat, V. F., Medic, S., Sabale, M., Rowles, J., Wijesekara, N., Martins, R. N., Fraser, P. E., & Newsholme, P. (2015) · Mediators of Inflammation · doi:10.1155/2015/105828 · Cited by 501 · see citing works
Craft, S., Raman, R., Chow, T. W., Rafii, M. S., Sun, C.-K., Rissman, R. A., Donohue, M. C., Brewer, J. B., Jenkins, C., Harless, K., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1840 · Cited by 389 · see citing works
Type 2 diabetes mellitus and biomarkers of neurodegeneration
Moran, C., Beare, R. J., Phan, T. G., Bruce, D. G., Callisaya, M. L., & Srikanth, V. K. (2015) · Neurology · doi:10.1212/wnl.0000000000001982 · Cited by 298 · see citing works
The role of type 2 diabetes in neurodegeneration
Verdile, G., Fuller, S. J., & Martins, R. N. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.008 · Cited by 276 · see citing works
Insulin resistance predicts brain amyloid deposition in late middle‐aged adults
Willette, A. A., Johnson, S. C., Birdsill, A. C., Sager, M. A., Christian, B., Baker, L. D., Craft, S., Oh, J. M., Statz, E. H., Hermann, B. P., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.03.011 · Cited by 262 · see citing works
A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status
Sood, S., Gallagher, I. J., Lunnon, K., Rullman, E., Keohane, A., Crossland, H., Phillips, B. E., Cederholm, T., Jensen, T., van Loon, L. J. C., et al. (2015) · Genome biology · doi:10.1186/s13059-015-0750-x · Cited by 240 · see citing works
Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology
Abner, E. L., Nelson, P. T., Kryscio, R. J., Schmitt, F. A., Fardo, D. W., Woltjer, R. L., Cairns, N. J., Yu, L., Dodge, H. H., Xiong, C., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.12.006 · Cited by 233 · see citing works
Is Alzheimer’s disease a systemic disease?
Morris, J. K., Honea, R. A., Vidoni, E. D., Swerdlow, R. H., & Burns, J. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.012 · Cited by 219 · see citing works
Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
Mullins, R. J., Diehl, T. C., Chia, C. W., & Kapogiannis, D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00118 · Cited by 217 · see citing works
Type 2 diabetes as a risk factor for cognitive impairment: current insights
Umegaki, H. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s48926 · Cited by 180 · see citing works
Intranasal Insulin for Alzheimer’s Disease
Hallschmid, M. (2021) · CNS Drugs · doi:10.1007/s40263-020-00781-x · Cited by 182 · see citing works
Roberts, R. O., Knopman, D. S., Cha, R. H., Mielke, M. M., Pankratz, V. S., Boeve, B. F., Kantarci, K., Geda, Y. E., Jack, C. R., Petersen, R. C., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.132647 · Cited by 162 · see citing works
Type 2 diabetes mellitus, brain atrophy, and cognitive decline
Moran, C., Beare, R. J., Wang, W., Callisaya, M. L., Srikanth, V. K., Initiative, A. D. N., Initiative, A. D. N., Weiner, M. W., Aisen, P., Weiner, M. W., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000006955 · Cited by 158 · see citing works
Glucose indices are associated with cognitive and structural brain measures in young adults
Weinstein, G., Maillard, P., Himali, J. J., Beiser, A., Au, R., Wolf, P. A., Seshadri, S. S., & DeCarli, C. S. (2015) · Neurology · doi:10.1212/wnl.0000000000001655 · Cited by 147 · see citing works
Vemuri, P., Knopman, D. S., Lesnick, T. G., Przybelski, S. A., Mielke, M. M., Graff‐Radford, J., Murray, M. E., Roberts, R. O., Vassilaki, M. E., Lowe, V. J., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0244 · Cited by 140 · see citing works
Insulin dysfunction and Tau pathology
Khoury, N. B. E., Gratuze, M., Papon, M.-A., Bretteville, A., & Planel, E. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00022 · Cited by 131 · see citing works
Emerging links between type 2 diabetes and Alzheimer's disease
Sridhar, G. R. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i5.744 · Cited by 123 · see citing works
Mayeda, E. R., Whitmer, R. A., & Yaffe, K. S. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.08.021 · Cited by 120 · see citing works
Insulin resistance in Alzheimer's disease
Diehl, T. C., Mullins, R. J., & Kapogiannis, D. (2016) · Translational research · doi:10.1016/j.trsl.2016.12.005 · Cited by 119 · see citing works
Hallschmid, M. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12934 · Cited by 113 · see citing works
Release of insulin produced by the choroid plexis is regulated by serotonergic signaling
Mazucanti, C. H., Liu, Q.-R., Lang, D., Huang, N., O’Connell, J. F., Camandola, S., & Egan, J. M. (2019) · JCI Insight · doi:10.1172/jci.insight.131682 · Cited by 101 · see citing works
Self-citationThe diabetic brain and cognition
Riederer, P., Korczyn, A. D., Ali, S. S., Bajenaru, O. A., Choi, M. S., Chopp, M., Dobrota, V. Đ., Grünblatt, E., Jellinger, K. A., Kamal, M. A., et al. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1763-2 · Cited by 96 · see citing works
Benedict, C., & Grillo, C. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00215 · Cited by 96 · see citing works
Review: Relationship of type 2 diabetes to human brain pathology
Pruzin, J. J., Nelson, P. T., Abner, E. L., & Arvanitakis, Z. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12476 · Cited by 88 · see citing works
Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art
de la Monte, S. M. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.856877 · Cited by 87 · see citing works
Laws, S. M., Gaskin, S., Woodfield, A., Srikanth, V. K., Bruce, D. G., Fraser, P. E., Porter, T., Newsholme, P., Wijesekara, N., Burnham, S. C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09577-4 · Cited by 89 · see citing works
Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation
Ekblad, L. L., Johansson, J. J., Helin, S., Viitanen, M. H., Laine, H. K., Puukka, P. J., Jula, A., & Rinne, J. O. (2018) · Neurology · doi:10.1212/wnl.0000000000005214 · Cited by 84 · see citing works
INSULIN RESISTANCE AND GRAY MATTER VOLUME IN NEURODEGENERATIVE DISEASE
Morris, J. K., Vidoni, E., Perea, R., Rada, R. C., Johnson, D. K., Lyons, K., Pahwa, R., Burns, J. M., & Honea, R. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.006 · Cited by 81 · see citing works
Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study
van Arendonk, J., Neitzel, J., Steketee, R. M. E., van Assema, D. M. E., Vrooman, H. A., Segbers, M., Ikram, M. A., & Vernooij, M. W. (2022) · Brain · doi:10.1093/brain/awac354 · Cited by 82 · see citing works
Hoscheidt, S. M., Starks, E. J., Oh, J. M., Zetterberg, H., Blennow, K., Krause, R. A., Gleason, C. E., Puglielli, L., Atwood, C., Carlsson, C. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160110 · Cited by 82 · see citing works
Type 2 Diabetes and Cognitive Impairment
Ryan, J. P., Fine, D. F., & Rosano, C. (2014) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988713516543 · Cited by 80 · see citing works
Starks, E. J., O’Grady, J. P., Hoscheidt, S. M., Racine, A. M., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., Puglielli, L., Asthana, S., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150072 · Cited by 79 · see citing works
Li, J., Zhang, Y., Lu, T., Liang, R., Wu, Z., Liu, M., Qin, L., Chen, H., Yan, X., Deng, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1037318 · Cited by 80 · see citing works
The Aging Metabolome—Biomarkers to Hub Metabolites
Sharma, R. B., & Ramanathan, A. (2020) · PROTEOMICS · doi:10.1002/pmic.201800407 · Cited by 76 · see citing works
True or false? Alzheimer’s disease is type 3 diabetes: Evidences from bench to bedside
Peng, Y., Yao, S.-Y., Chen, Q., Jin, H., Du, M., Xue, Y.-H., & Liu, S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102383 · Cited by 76 · see citing works
Melatonin Therapy in Patients with Alzheimer’s Disease
Cardinali, D. P., Vigo, D. E., Olivar, N., Vidal, M., & Brusco, L. I. (2014) · Antioxidants · doi:10.3390/antiox3020245 · Cited by 73 · see citing works
Midlife lipid and glucose levels are associated with Alzheimer's disease
Zhang, X., Tong, T., Chang, A., Ang, T. F. A., Tao, Q., Auerbach, S., Devine, S., Qiu, W. Q., Mez, J., Massaro, J., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12641 · Cited by 65 · see citing works
Zangerolamo, L., Vettorazzi, J. F., Solon, C., Bronczek, G. A., Engel, D. F., Kurauti, M. A., Soares, G. M., Rodrigues, K. S., Velloso, L. A., Boschero, A. C., et al. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111116 · Cited by 66 · see citing works
Insulin signaling: An opportunistic target to minify the risk of Alzheimer’s disease
Pardeshi, R., Bolshette, N. B., Gadhave, K., Ahire, A., Ahmed, S., Cassano, T., Gupta, V. B., & Lahkar, M. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.05.004 · Cited by 65 · see citing works
Metabolic Syndrome and Amyloid Accumulation in the Aging Brain
Gómez, G., Beason‐Held, L. L., Bilgel, M., An, Y., Wong, D. F., Studenski, S. A., Ferrucci, L., & Resnick, S. M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180297 · Cited by 64 · see citing works
Self-citationDiabetes and Alzheimer’s Disease: A Link not as Simple as it Seems
Salas, I. H., & Strooper, B. D. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2690-9 · Cited by 65 · see citing works
Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology
Pruzin, J. J., Schneider, J. A., Capuano, A. W., Leurgans, S. E., Barnes, L. L., Ahima, R. S., Arnold, S. E., Bennett, D. A., & Arvanitakis, Z. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000172 · Cited by 63 · see citing works
Prediabetes-induced vascular alterations exacerbate central pathology in APPswe/PS1dE9 mice
Ramos‐Rodríguez, J. J., Ortiz-Barajas, O., Gamero-Carrasco, C., de la Rosa, P. R., Infante‐Garcia, C., Zopeque-Garcia, N., Lechuga-Sancho, A. M., & Garcı́a-Alloza, M. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.06.005 · Cited by 60 · see citing works
Task-Induced Brain Activity Patterns in Type 2 Diabetes: A Potential Biomarker for Cognitive Decline
Marder, T. J., Flores, V. L., Bolo, N. R., Hoogenboom, W. S., Simonson, D. C., Jacobson, A. M., Foote, S., Shenton, M. E., Sperling, R. A., & Musen, G. (2014) · Diabetes · doi:10.2337/db13-1783 · Cited by 60 · see citing works
Diabetes and cognitive decline
Bellia, C., Lombardo, M., Meloni, M., Della‐Morte, D., Bellia, A., & Lauro, D. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2021.07.006 · Cited by 58 · see citing works
Neuroimaging and its Relevance to Understanding Pathways Linking Diabetes and Cognitive Dysfunction
Moran, C., Beare, R. J., Phan, T. G., STARKSTEIN, S. E., Bruce, D. G., Mizrahi, R., & Srikanth, V. K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161166 · Cited by 53 · see citing works
Epidemiological Approaches to Understanding the Link Between Type 2 Diabetes and Dementia
Sutherland, G. T., Lim, J., Srikanth, V. K., & Bruce, D. G. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161194 · Cited by 53 · see citing works
van Gils, V., Rizzo, M., Côté, J., Viechtbauer, W., Fanelli, G., Salas‐Salvadó, J., Wimberley, T., Bulló, M., Fernández‐Aranda, F., Dalsgaard, S., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105604 · Cited by 50 · see citing works
Westwood, S., Liu, B., Baird, A. L., Anand, S. N., Nevado‐Holgado, A. J., Newby, D., Pikkarainen, M., Hallikainen, M., Kuusisto, J., Streffer, J. R., et al. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0258-6 · Cited by 50 · see citing works
Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline
Tortelli, R., Lozupone, M., Guerra, V., Barulli, M. R., Imbimbo, B. P., Capozzo, R., Grasso, A. C., Tursi, M., Dio, C. D., Sardone, R., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170153 · Cited by 50 · see citing works
Brain amyloid load and its associations with cognition and vascular risk factors in FINGER Study
Kemppainen, N. M., Johansson, J. J., Teuho, J., Parkkola, R. K., Joutsa, J., Ngandu, T., Solomon, A., Stephen, R., Liu, Y., Hänninen, T., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004827 · Cited by 46 · see citing works
Effects of Exercise on Type 2 Diabetes Mellitus-Related Cognitive Impairment and Dementia
Callisaya, M. L., & Nosaka, K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161154 · Cited by 45 · see citing works
Salas, I. H., Weerasekera, A., Ahmed, T., Callaerts‐Vegh, Z., Himmelreich, U., D’Hooge, R., Balschun, D., Saido, T. C., Strooper, B. D., & Dotti, C. G. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.02.001 · Cited by 45 · see citing works
Non-Alzheimer's disease—related memory impairment and dementia
Arlt, S. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.4/sarlt · Cited by 44 · see citing works
Pablo‐Fernández, E. D., Courtney, R. J., Rockliffe, A., Gentleman, S., Holton, J. L., & Warner, T. T. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12728 · Cited by 43 · see citing works
Diabetes Mellitus and Cognition
Frison, É., Proust‐Lima, C., Mangin, J., Habert, M., Bombois, S., Ousset, P., Pasquier, F., Hanon, O., Paquet, C., Gabelle, A., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012440 · Cited by 42 · see citing works
Guo, C., Zhang, S., Li, J., Ding, C., Yang, Z., Chai, R., Wang, X., & Wang, Z. (2016) · Scientific Reports · doi:10.1038/srep29396 · Cited by 41 · see citing works
Insulin Resistance Predicts Postoperative Cognitive Dysfunction in Elderly Gastrointestinal Patients
He, X., Long, G., Quan, C., Zhang, B., Chen, J., & Ouyang, W. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00197 · Cited by 40 · see citing works
Zhou, X., Yang, Q., Xie, Y., Sun, J., Hu, J. R., Qiu, P., Cao, W., & Wang, S. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.11.002 · Cited by 40 · see citing works
Endosomal-lysosomal dysfunction in metabolic diseases and Alzheimer's disease
de Almeida, M. F., Bahr, B. A., & Kinsey, S. T. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.02.012 · Cited by 40 · see citing works
Wu, M., Cheng, Y., Zhang, R., Han, W., Jiang, H., Bi, C., Zhang, Z., Ye, M., Lin, X., & Liu, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117228 · Cited by 38 · see citing works
Impaired fasting glucose is associated with increased regional cerebral amyloid
Morris, J. K., Vidoni, E. D., Wilkins, H., Archer, A. E., Burns, N. C., Karcher, R. T., Graves, R. S., Swerdlow, R. H., Thyfault, J. P., & Burns, J. M. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.017 · Cited by 36 · see citing works
Hendrix, R. D., Ou, Y., Davis, J. E., Odle, A. K., Groves, T. R., Allen, A. R., Childs, G. V., & Barger, S. W. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.10.001 · Cited by 33 · see citing works
Tian, N., Fa, W., Dong, Y., Liu, R., Liu, C., Liu, K., Mao, M., Zhu, M., Liang, X., Wang, N., et al. (2023) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12426 · Cited by 34 · see citing works
Lu, Y., Jiang, X., Liu, S., & Li, M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00271 · Cited by 34 · see citing works
Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer’s Disease?
Codocedo, J. F., Ríos, J. A., Godoy, J. A., & Inestrosa, N. C. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9201-7 · Cited by 34 · see citing works
Testosterone deficiency, insulin-resistant obesity and cognitive function
Pintana, H., Chattipakorn, N., & Chattipakorn, S. C. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9655-3 · Cited by 33 · see citing works
New cardiovascular targets to prevent late onset Alzheimer disease
Claassen, J. A. H. R. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.022 · Cited by 33 · see citing works
Kangwan, N., Pratchayasakul, W., Kongkaew, A., Pintha, K., Chattipakorn, N., & Chattipakorn, S. C. (2021) · Nutrients · doi:10.3390/nu13093141 · Cited by 33 · see citing works
Shwe, T., Bo‐Htay, C., Ongnok, B., Chunchai, T., Jaiwongkam, T., Kerdphoo, S., Kumfu, S., Pratchayasakul, W., Pattarasakulchai, T., Chattipakorn, N., et al. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111465 · Cited by 32 · see citing works
Diabetes and dementia: Clinical perspective, innovation, knowledge gaps
Savelieff, M. G., Chen, K. S., Elzinga, S. E., & Feldman, E. L. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108333 · Cited by 34 · see citing works
Metformin in the Prevention of Alzheimer's Disease and Alzheimer's Disease Related Dementias
Tahmi, M., & Luchsinger, J. A. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.113 · Cited by 31 · see citing works
Byun, M. S., Kim, H. J., Yi, D., Choi, H. J., Baek, H., Lee, J. H., Choe, Y. M., Sohn, B. K., Lee, J., Lee, Y., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.07.004 · Cited by 31 · see citing works
Association of type 2 diabetes GWAS loci and the risk of Parkinson's and Alzheimer's diseases
Chung, S. J., Kim, M., Kim, J., Ryu, H., Kim, Y. J., Kim, S. Y., & Lee, J. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.10.010 · Cited by 31 · see citing works
Antidiabetic therapies and Alzheimer disease.
Bendlin, B. B. (2019) · PubMed Central · Cited by 30 · see citing works
Pre-Diabetes, but not Type 2 Diabetes, Is Related to Brain Amyloid in Late Middle-Age
Luchsinger, J. A., Palta, P., Rippon, B., Sherwood, G., Soto, L., Ceballos, F., Laing, K. K., Igwe, K. C., He, H., Razlighi, Q. R., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200232 · Cited by 30 · see citing works
Ourry, V., Binette, A. P., St‐Onge, F., Strikwerda‐Brown, C., Chagnot, A., Poirier, J., Breitner, J. C. S., Arenaza‐Urquijo, E. M., Rabin, J. S., Buckley, R. F., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.09.003 · Cited by 28 · see citing works
Yang, H. J., Kwon, D. Y., Kim, M. J., Kang, S., Moon, N. R., Daily, J. W., & Park, S. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0005-6 · Cited by 29 · see citing works
Pratchayasakul, W., Jinawong, K., Pongkan, W., Jaiwongkam, T., Arunsak, B., Chunchai, T., Tokuda, M., Chattipakorn, N., & Chattipakorn, S. C. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1840050 · Cited by 26 · see citing works
Carmichael, O. T., Neiberg, R. H., Dutton, G. R., Hayden, K. M., Horton, E., Pi-Sunyer, F. X., Johnson, K. C., Rapp, S. R., Spira, A. P., & Espeland, M. A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa591 · Cited by 24 · see citing works
Ferreira, L. K., Tamashiro-Duran, J. H., Squarzoni, P., Duran, F., Alves, T. C. T. F., Buchpiguel, C. A., & Busatto, G. F. (2014) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1275 · Cited by 23 · see citing works
Animal Models of Alzheimer’s Disease
Newman, M., Kretzschmar, D., Khan, I., Chen, M., Verdile, G., & Lardelli, M. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00040-1 · Cited by 24 · see citing works
Cortisol: Mediator of association between Alzheimer’s disease and diabetes mellitus?
Notarianni, E. L. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.04.008 · Cited by 23 · see citing works
Pekkala, T., Hall, A., Mangialasche, F., Kemppainen, N. M., Mecocci, P., Ngandu, T., Rinne, J. O., Soininen, H. S., Tuomilehto, J., Kivipelto, M., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200145 · Cited by 23 · see citing works
Carmichael, O. T., Stuchlik, P. M., Pillai, S. R., Biessels, G. J., Dhullipudi, R., Madden‐Rusnak, A., Martin, S., Hsia, D. S., Fonseca, V. A., & Bazzano, L. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02750 · Cited by 23 · see citing works
Noguchi‐Shinohara, M., Yuki-Nozaki, S., Abe, C., Mori, A., Horimoto, M., Yokogawa, M., Ishida, N., Suga, Y., Ishizaki, J., Ishimiya, M., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215153 · Cited by 21 · see citing works
The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults
Ennis, G. E., Betthauser, T. J., Koscik, R. L., Chin, N. A., Christian, B. T., Asthana, S., Johnson, S. C., & Bendlin, B. B. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01180-2 · Cited by 26 · see citing works
Shie, F., Shiao, Y.-J., Yeh, C.-W., Lin, C.-H., Tzeng, T.-T., Hsu, H.-C., Huang, F.-L., Tsay, H.-J., & Liu, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134531 · Cited by 21 · see citing works
Alzarea, E. A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alexiou, A. T., Papadakis, M., Beshay, O. N., & Batiha, G. E. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08832-6 · Cited by 19 · see citing works
Clusterin as a Potential Biomarker of Obesity-Related Alzheimer’s Disease Risk
Bradley, D. P. (2020) · Biomarker Insights · doi:10.1177/1177271920964108 · Cited by 19 · see citing works
Arunsak, B., Pratchayasakul, W., Amput, P., Chattipakorn, K., Tosukhowong, T., Kerdphoo, S., Jaiwongkum, T., Thonusin, C., Palee, S., Chattipakorn, N., et al. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108470 · Cited by 19 · see citing works
Peripheral Aβ acts as a negative modulator of insulin secretion
Shigemori, K., Nomura, S., Umeda, T., Takeda, S., & Tomiyama, T. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117723119 · Cited by 18 · see citing works
Palix, C., Felisatti, F., Gonneaud, J., Kuhn, E., Mézenge, F., Landeau, B., Chocat, A., Quillard, A., Egret, S., Delarue, M., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.06.004 · Cited by 18 · see citing works
Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer’s Disease
Morris, J. K., Uy, R. A. Z., Vidoni, E. D., Wilkins, H., Archer, A. E., Thyfault, J. P., Miles, J. M., & Burns, J. M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170148 · Cited by 18 · see citing works
- Authors
- Thambisetty, M., Metter, E. J., Yang, A., Dolan, H., Marano, C., Zonderman, A. B., Troncoso, J. C., Zhou, Y., Wong, D. F., Ferrucci, L., Egan, J., Resnick, S. M., & O’Brien, R. J.
- Affiliations
- National Institute on Aging (US)
- Johns Hopkins University (US)
- Corresponding author
- O’Brien, Richard J.
- ORCID
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2013-09-01
- Volume
- 70
- Issue
- 9
- Pages
- 1167
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC3934653
- OpenAlex
- W2160143874
- Cited by
- 155
- References
- 37
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 13 · 2023: 9 · 2022: 9 · 2021: 11 · 2020: 14 · 2019: 9 · 2018: 11 · 2017: 20 · 2016: 11 · 2015: 17 · 2014: 19 · 2013: 4
- FWCI
- 12.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (U19AG033655, U01AG033655, P50AG005146, P50AG05146)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- Alzheimer's disease, impaired glucose tolerance, insulin resistance, diabetes mellitus, hyperinsulinemia, hyperglycemia, brain amyloid burden, 11C-PiB PET, autopsy neuropathology, glucose homeostasis, oral glucose tolerance test, Baltimore Longitudinal Study of Aging, vascular disease, cognitive impairment
- MeSH terms
- Aged, Aged, 80 and over, Aging, Alzheimer Disease, Aniline Compounds, Cognition Disorders, Female, Humans, Insulin Resistance, Longitudinal Studies, Male, Prospective Studies, Radionuclide Imaging, Thiazoles, Baltimore, Glucose Intolerance, Benzothiazoles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
